Syra Health Corp. (NASDAQ:SYRA) Short Interest Down 37.7% in August

Syra Health Corp. (NASDAQ:SYRAGet Free Report) was the target of a significant drop in short interest in August. As of August 15th, there was short interest totalling 240,300 shares, a drop of 37.7% from the July 31st total of 385,800 shares. Based on an average daily volume of 130,600 shares, the short-interest ratio is currently 1.8 days. Approximately 5.5% of the shares of the stock are sold short.

Syra Health Trading Down 4.8 %

NASDAQ SYRA traded down $0.05 during trading hours on Wednesday, reaching $1.00. 74,589 shares of the stock traded hands, compared to its average volume of 949,855. The stock has a 50 day simple moving average of $1.30 and a two-hundred day simple moving average of $1.48. Syra Health has a 1 year low of $0.81 and a 1 year high of $8.37.

Syra Health (NASDAQ:SYRAGet Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.19) by ($0.02). The company had revenue of $1.97 million during the quarter, compared to analysts’ expectations of $1.79 million. Syra Health had a negative return on equity of 201.13% and a negative net margin of 59.22%. Research analysts forecast that Syra Health will post -0.86 EPS for the current fiscal year.

About Syra Health

(Get Free Report)

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions.

Read More

Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.